Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Navigating the Complex Landscape of Utilization Review in Workers' Compensation
Learn about the crucial role of Utilization Review (UR) in the workers' compensation system, the importance of regulatory compliance, and the impact of state-by-state jurisdictional nuances.
Enlyte’s Q2 Medical Price Index Shows Increases In Comp and Auto Injury Services
Medical costs nationally have risen 11% in workers’ comp and 5% in auto first-party over the past four years, despite a slowing of growth over the past two years, according to new data released by Enlyte today.
Return-to-work strategies for LGBTQ+ Injured Employees
Celebrate Pride Month by reflecting on the progress of LGBTQ+ equality and addressing health care disparities. Join Genex case manager Chikita Mann, MSN, RN, CCM, as she explores this crucial topic.
Looking Beyond the Numbers of Enlyte’s Medical Price Index
In this quarter’s Enlyte Executive Insight, Michele Hibbert, senior vice president of regulatory compliance management, discusses the latest results from Enlyte’s medical price index and how it impacts the industry.
Enlyte Quarterly Medical Price Index - Q2
As reported by the Bureau of Labor and Statistics (BLS) for April 2024, the consumer price index in the United States increased 3.4% over the preceding 12 months. The medical care index rose 0.4% in April 2024 after rising 0.5% in March 2024. The index for hospital services increased 0.6% over the month and the index for physician’s services increased 0.1% which would be compared to Enlyte’s data in this report.
Enlyte Pharmacists Discuss a Changing Workers’ Comp Pharmacy Landscape
Workers' compensation pharmacy is constantly evolving, from tackling the opioid crisis, to the rise of compounding pharmacies, to the pandemic. Amidst these changes, pharmacy benefit managers must constantly evolve to address an array of industry changes. In our final Enlytening Conversation our pharmacists discuss how changes within the industry as a whole including physician shortages, digital therapeutics, biopsychosocial approaches, new drug treatments, and much more are driving the need for constant planning and innovation to stay a step ahead in this ever-changing landscape.